2371 related articles for article (PubMed ID: 28245881)
1. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
8. Treatment of five or more brain metastases with stereotactic radiosurgery.
Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
[TBL] [Abstract][Full Text] [Related]
9. The role of whole-brain radiation therapy after stereotactic radiation surgery for brain metastases.
Hasan S; Shah AH; Bregy A; Albert T; Markoe A; Stoyanova R; Thambuswamy M; Komotar RJ
Pract Radiat Oncol; 2014; 4(5):306-315. PubMed ID: 25194099
[TBL] [Abstract][Full Text] [Related]
10. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
11. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
[TBL] [Abstract][Full Text] [Related]
12. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
13. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
[TBL] [Abstract][Full Text] [Related]
15. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
Chen L; Shen C; Redmond KJ; Page BR; Kummerlowe M; Mcnutt T; Bettegowda C; Rigamonti D; Lim M; Kleinberg L
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):939-947. PubMed ID: 28602418
[TBL] [Abstract][Full Text] [Related]
16. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
17. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
Lester-Coll NH; Dosoretz AP; Yu JB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
[TBL] [Abstract][Full Text] [Related]
18. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
19. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
[TBL] [Abstract][Full Text] [Related]
20. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]